CAHP Statement: Renewed SB 17 Lawsuit Signals PhRMA’s Continued Unwillingness to Acknowledge Their Outsized Role in the High-Priced Drug Crisis

CAHP Statement: Renewed SB 17 Lawsuit Signals PhRMA’s Continued Unwillingness to Acknowledge Their Outsized Role in the High-Priced Drug Crisis